Clinical Trial Update: Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Renexin Tablet in patients with recurrent vestibulopathy has been terminated. No results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vestibulopathy

Drugs mentioned

• Renexin Tablet

Snippet

Sponsor: Jong Woo Chung | Conditions: Recurrent Vestibulopathy | Phase 3 | Status: TERMINATED